What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
MDT upgrade...Target ..$49/sh      6-Nov-09 02:03 pm    
Medtronic (MDT)

Credit Suisse upgrades to outperform from neutral, adds to Focus List; raises price target

Credit Suisse analyst Kristen Stewart said on Nov. 5 that Medtronic's base businesses, particularly cardiac rhythm management and spinal products, are showing signs of stability. Stewart said the company is delivering on its cost savings and operating margin leverage opportunities.

The analyst noted that over the next year and beyond, Medtronic will launch a series of new products across all divisions, most notably within the cardiac rhythm management and diabetes areas, which should accelerate underlying sales growth. She believes the stock's current valuation largely discounts a "worst-case scenario" and raised her $41 price target to $49.


Sentiment : Buy
Rating :
 (1 Rating)
Rate it:
awful/not related to \pooraveragegoodexcellent

allelerow

Male


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
MDT upgrade...Target ..$49/sh
allelerow (1 Rating) 6-Nov-09 02:03 pm  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Medtronic, Inc. (MDT)

Chart for Medtronic, Inc. (MDT)
On Nov 25: 43.18 Down 0.07 (0.16%)
Symbol Lookup